Search Market Research Report
Blood Filters Market Size, Share Global Analysis Report, 2022 – 2028
Blood Filters Market By Product (40 Microns and 70 Microns, 100 Microns and 170 Microns, Others), By Material (Polycarbonate, Polyester, ABS), By Application (Blood Processing, Blood Transfusion), By End-User (Blood Banks, Hospitals, Others), and By Region - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast 2022 – 2028
Industry Insights
[217+ Pages Report] According to Facts and Factors, the Global Blood Filters Market was valued at USD 381.05 million in 2021 and is predicted to increase at a CAGR of 3.01% to USD 424.06 million by 2028. The study examines the market in terms of revenue in each of the major regions, which are classified into countries. The report analyses the global blood filters market’s drivers and restraints, as well as the impact they have on-demand throughout the projection period. In addition, the report examines global opportunities in the blood filter market.
Market Overview
A blood filter is a screen-type filter constructed of woven mesh made of polyester or nylon that is used to perform filtration between the product bag and the patient. These filters are designed to keep patients safe from macro-aggregates and non-blood component particulate matter that could be harmful if they reach the bloodstream. During a blood transfusion, they remove macro-aggregates such as micro-aggregate sites and fibrin aggregates. The fast increase in global illness burden and trauma cases is increasingly fuelling the global need for blood transfusions. In addition, the growing elderly population and the increase in inpatient surgical operations are also boosting the worldwide blood filter market.
Growth Drivers
The increased number of surgical procedures performed as a result of car accidents and injuries is expected to significantly boost the market growth. An increase in the prevalence of blood illnesses such as anemia, erythrocytosis, leukocytosis, leukopenia, and thrombocytosis is also driving the blood filter market. Moreover, increased consumer awareness and increasing acceptance of blood transfusion filters in developing nations are projected to generate profitable prospects for market participants during the study period.
One of the issues is a lack of investment in healthcare infrastructure and severe government policies, particularly in developing countries when compared to developed countries. Furthermore, the high cost of tests, instruments, and reagents, combined with a lack of experienced people to handle automated diagnostic solutions, is one of the factors restricting the growth of the market during the forecast period.
COVID – 19 Impact
The covid-19 pandemic caused substantial hurdles to the healthcare system throughout the world. It had a negative impact on the growth of the blood transfusion filter market since patients rescheduled their appointments due to a significant increase in covid-19 cases across regions. Furthermore, supply chain delays caused by the imposition of the lockdown hampered market expansion. Due to the obvious fear of coronavirus infection, people only left their homes for needed services, which hampered market expansion for a brief time.
Segmentation Analysis
The global blood filters market is segregated based on product, material, application, end-user, and region.
In terms of End Users, the blood banking facility market is expected to rise rapidly. Blood transfusion filters are used in blood banks to protect patients from contamination that may occur during donation. They filter out contaminants and particles before infusing them into their bloodstream, perhaps saving them from obtaining infected or tainted blood. The whole blood filter removes red blood cells, white blood cells, and platelets, whereas the platelet transfusion only removes red blood cells and white blood cells. These devices considerably reduce the dangers associated with high-risk patients who require blood transfusions on a regular basis due to chronic kidney disease (CKD) or malignancy.
In terms of Application, the blood transfusion sector is expected to have the largest market share during the forecast period, and this dominance is expected to last throughout the projected period. The increasing prevalence of blood-related diseases such as hemophilia, cancer, thrombocytopenia, and others, as well as chronic kidney disease (CKD), has raised the need for complete blood transfusion.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 381.05 Million |
Projected Market Size in 2028 |
USD 424.06 Million |
CAGR Growth Rate |
3.01% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
Asahi Kasei Corporation, Fresenius Kabi AG, Macopharma, Haemonetics Corporation, Infomed SA, KANEKA CORPORATION, Kawasumi laboratories. Inc., Sefar AG, Shandong Zhongbaokang Medical Implements Co. Ltd., Nanjing Shuangwei Biotechnology Co. Ltd., and Others |
Key Segment |
By Product, Material, Application, End-User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Landscape
North America leads the market in terms of revenue share because of the growing elderly population and the rising prevalence of chronic diseases. The region's supremacy is attributable to increased adoption of the blood transfusion method, increased public awareness about blood donations, and developed healthcare infrastructure. The expansion of the regional market can be ascribed to an increase in surgical operations as well as an increase in the geriatric population. The region's biggest economies, particularly the United States and Canada, contribute significantly to the regional market value.
Competitive Landscape
The report contains qualitative and quantitative research on the global Blood Filters Market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company's global presence, competitors, service offers, and standards.
List of Key Players in the Global Blood Filters Market:
- Asahi Kasei Corporation
- Fresenius Kabi AG
- Macopharma
- Haemonetics Corporation
- Infomed SA
- KANEKA CORPORATION
- Kawasumi laboratories. Inc.
- Sefar AG
- Shandong Zhongbaokang Medical Implements Co. Ltd.
- Nanjing Shuangwei Biotechnology Co. Ltd.
The global blood filters market is segmented as follows:
By Product Segment Analysis
- 40 Microns and 70 Microns
- 100 Microns and 170 Microns
- Others
By Material Segment Analysis
- Polycarbonate
- Polyester
- ABS
- Others
By Application Segment Analysis
- Blood Processing
- Blood Transfusion
By End-User Segment Analysis
- Blood Banks
- Hospitals
- Others
By Regional Segment Analysis
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Content
Industry Major Market Players
- Asahi Kasei Corporation
- Fresenius Kabi AG
- Macopharma
- Haemonetics Corporation
- Infomed SA
- KANEKA CORPORATION
- Kawasumi laboratories. Inc.
- Sefar AG
- Shandong Zhongbaokang Medical Implements Co. Ltd.
- Nanjing Shuangwei Biotechnology Co. Ltd.
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors